The antiinfective medicine sales in Italy, expressed in US Dollars PPP per capita, show a modest and steady increase from 2024 to 2028. After matching the given sequence with two similar lines, this trend indicates stable growth with yearly sales rising gradually by approximately 0.3% each year from 72.3 in 2024 to 73.2 in 2028. Notably, in 2023, the actual data stood close to 72.3, suggesting a consistent growth trajectory. Over the past years, the compound annual growth rate (CAGR) reflects minimal yet positive yearly increments, confirming a stable market performance.
Future trends to watch for may include the impact of healthcare policy changes and technological advancements in treatment methods. Additionally, monitoring global health threats and antibiotic resistance could significantly influence demand, alongside burgeoning pharmaceutical innovations.
